Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide notice was added explaining NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe 403 error content and its navigation elements were removed, and the page now presents the standard study details.SummaryDifference0.5%

- Check43 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the prior study content with an access-denied message. The presence of a 403 header and related HTML indicates the resource is blocked or unavailable to the public.SummaryDifference18%

Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.